Thomas Seidl is a seasoned executive in the field of diabetes care, currently serving as Chief Executive Officer at Pacific Diabetes Technologies Inc since October 2020, after previously holding the role of Chief Science Officer at the same company from July 2017 to October 2020. Prior to that, Thomas Seidl contributed to research at Portland State University from 2012 to 2017 as part of the Stuart Research Group, earning a Doctor of Philosophy (PhD) in Chemistry. Additionally, experience includes a managerial position in polymer development at Bayer HealthCare from 2006 to 2010, showcasing a strong background in both management and scientific research.
Org chart
Sign up to view 5 direct reports
Get started